← GLOB deep-dive | EPAM deep-dive | SCREEN
Robert Half Inc. (RHI) — short-thesis deep-dive
New-category short candidate: staffing/placement (not direct services like EPAM/GLOB). Places contract + permanent hires in accounting, finance, legal, admin, and tech. Protiviti = consulting sub. CIK 0000315213. Generated 2026-04-18.
⚠ SHORT-SQUEEZE WARNING: RHI sits at 38.74% short interest / float with 23.0M shares short and 6.96 days to cover. This is the most crowded position among all staffing/IT-services peers in the universe — materially more crowded than EPAM (18.1%) or GLOB (14.8%). Any read as a “short” on RHI must be structured as a defined-risk put spread, not outright long puts. Position sizing must assume a plausible +30–50% squeeze on any mild beat. The trade structure section below prices a specific spread.
Short thesis (bottom line): Robert Half is the staffing-industry expression of the same AI-labor-demand compression thesis that drives the EPAM/GLOB short, but routed through a different business model. RHI doesn’t bill hours to Fortune 500s for bespoke engineering like EPAM — it places contract and permanent hires in accounting & finance (largest division), tech (Robert Half Technology), legal, and admin, charging a placement fee on perm or a margin on temp billing. FY2025 revenue was −5.8%, permanent-placement revenue decelerated inside Q4 from −5.9% to −11.0% in December to −9.4% in the first three weeks of January (peer_sources/RHI_transcript_Q4_2025.txt), talent-solutions operating margin dropped to 1.1%, and 13 consecutive quarters of absolute revenue recession have already cut internal talent-solutions headcount −3.2% YoY — a quiet workforce reduction buried in an SG&A footnote. Bill-rate growth is eroding: 3.8% → 3.7% → 3.2% across the last three quarters on a mix-adjusted basis. Protiviti adjusted gross margin is down ~200–280bps YoY. Accounting/finance (bookkeeping, AP/AR, reconciliations), paralegal/contract review, and contract software engineering are precisely the job categories LLM automation hits first — and RHI places all three.
Edge vs the consensus: Barclays cut to $25 citing “low-to-no AI disruption exposure” — the sell-side bull case literally argues RHI is insulated from AI (CEO Waddell on the Q4 call cites an Oxford Economics study and reframes GenAI resume-fraud as a tailwind for RHI’s candidate-authentication moat). This is the cleanest mispricing in the peer set: sell-side still sees RHI as an AI-neutral cyclical while the tape says it’s both cyclical and structurally impaired. But that view is also why the short is crowded to 38.7% of float — a squeeze-on-any-beat setup that eclipses EPAM’s.
Signal strength: MEDIUM on direction (fundamentals rolling over, Q1 2026 guide −3% to −6% YoY adj, CEO in FULL denial posture), but CONSTRAINED by (a) 38.7% short-interest crowding, (b) analyst price target only $30 mean vs $27 spot = +9% upside (sell-side partially capitulated; crowded SHORT), and (c) asymmetric squeeze risk in a long-duration recovery narrative that only needs ONE better-than-guide Q1 2026 print to detonate. Trade is expressible only as a defined-risk put spread, not outright long puts.
Signal grid
Each row is one angle on the RHI thesis. Red = strong short, orange = medium, yellow = weak, green = counter-signal, gray = neutral. Quotes cite peer_sources/RHI_transcript_Q3_2025.txt and _Q4_2025.txt.
| Angle | Key finding | Signal |
| 1 | Revenue trajectory | 13 consecutive quarters of absolute revenue recession. Q3’25 −8%, Q4’25 −7% adj. Q1 2026 guide −3% to −6% adj. “Sequential growth for first time since Q2 2022” (Q3’25) is a turn off the floor, not growth. | strong |
| 2 | Perm-placement acceleration DOWN | Q4 full −5.9% → December −11.0% → Jan 3-wk −9.4%. Discretionary hiring (the highest-margin product) deteriorating fastest exiting the quarter. Directly contradicts the “inflection” narrative from Q3 2025. | strong |
| 3 | Segment mix — AI exposure | Largest placement division is accounting & finance (AP/AR, bookkeeping, recs — first-wave LLM targets). Robert Half Technology places contract software engineers (same EPAM/GLOB exposure). Legal (contract review / paralegal) also placed. All three are AI-automation first-wave. | strong |
| 4 | Bill-rate deceleration | Mix-adjusted contract bill-rate growth: Q2 3.8% → Q3 3.7% → Q4 3.2%. Pricing lever fading concurrent with volume trying to turn — margin sandwich. | medium-strong |
| 5 | Talent-solutions op margin near breakeven | Q4’25 adjusted OI for talent solutions was 1.1% of revenue ($9M). 2026 guide is 0%–3%. Small top-line miss flips the segment to operating loss. | strong |
| 6 | Quiet workforce reduction | Internal talent-solutions employees ended 2025 at 7,400, down 3.2% YoY. RHI did not brand this as an “optimization plan” like GLOB did, but the cut is already on the tape. | medium |
| 7 | Protiviti GM compression | Adj GM Q3’25 23.0% vs 25.8% prior year (−280bps); Q4 22.8% vs 25.1% (−230bps). “Longer sales cycles and smaller-sized new engagements” — identical vocab to GLOB/EPAM. Consulting business is breaking the same way. | medium-strong |
| 8 | CEO AI-denial posture | Waddell Q4’25: “most of the evidence suggests a negligible impact so far on our areas of employment… feedback from our SMB clients indicates that potential future labor savings from AI are not a material factor in current headcount decisions.” Cites Oxford Economics defense. Reframes GenAI resume-gaming as tailwind for RHI vetting services. | strong (as mispricing) |
| 9 | Sell-side still not capitulated | 9 analysts, target mean $30 ($27 median, high $50, low $20), current $27.44 = only +9.3% upside. Barclays just cut PT $36→$25 citing “low-to-no AI disruption exposure” — the cut direction is right but the narrative is inverted. Room for other analysts to cluster-cut if Q1/Q2 2026 misses. | medium |
| 10 | Short crowding — EXTREME | 38.74% of float short, 23.0M shares (+4.72% MoM from 22.0M), days-to-cover 6.96. This is by a wide margin the most crowded short in the IT-services/staffing peer set (EPAM 18%, GLOB 14.8%). Squeeze-on-any-beat setup. | counter (squeeze risk) |
| 11 | Valuation trap | Fwd P/E 12.0x vs peer median 9.1x = +33% premium. EV/EBITDA 19.5x vs peer median 7.3x looks extreme — but that’s because TTM EBITDA is $128M (2.4% margin) near trough. If EBITDA normalizes to ~$400M, EV/EBITDA compresses to ~6x — same as peers. The apparent multiple gap is cyclical, not structural. | weak |
| 12 | Dividend-defender floor | $2.36/yr dividend ($0.59/q) = 8.6% yield at $27.44. TTM payout not covered by GAAP earnings (~$0.68 EPS). Dividend-focused holders will backstop the stock unless a cut is signaled. Key floor around $25–$26. | counter (support) |
| 13 | Options chain — thin & positive put skew | Only 4 expirations through Dec 2026; longest = 243 DTE. Dec’26 OI on $25P = 283. Put-call ATM skew is POSITIVE (puts bid 7–10 vol points HIGHER than calls at 60–243 DTE) — opposite of GLOB/EPAM. The market is already paying up for puts. Naked long puts are expensive; spreads cheap the trade. | strong (mechanical) |
| 14 | vs EPAM — different model, same thesis | RHI monetizes per-placement-fee, not billable hours. But the underlying demand driver (accounting/legal/tech knowledge-worker labor) is the same the LLMs are displacing. RHI’s cyclicality adds an extra vector: a 2026 macro soft patch alone (without AI) drops it further. | medium |
Top 5 red flags (with direct quotes)
1. Permanent-placement accelerating DOWN exiting Q4 2025 — the highest-margin product is deteriorating fastest, not inflecting.
The perm-placement fee is the purest leading indicator of client hiring confidence (no margin from contract labor pass-through). RHI reported on the Q4 call:
“Permanent placement revenues in December were down 11.0 percent versus December 2024. This compares to a 5.9 percent decrease for the full quarter. For the first three weeks in January, permanent placement revenues were down 9.4 percent compared to the same period in 2025.” — CFO Buckley, Q4 2025 call (RHI_transcript_Q4_2025.txt)
This directly contradicts the Q3 2025 “inflection” story, where Buckley pointed to Oct 3-week perm trending at −3.3%. That October improvement
reversed hard. The “sequential growth” framing is being driven entirely by contract labor volume (lower-margin) while the profit engine backslides.
2. CEO Waddell in full AI-denial posture — Oxford Economics defense on the record, reframes GenAI as tailwind.
“While perspectives on the medium- to long-term structural impact of AI on the labor market vary greatly, most of the evidence suggests a negligible impact so far on our areas of employment, particularly among small businesses. For example, a very recent study by Oxford Economics concludes that ‘firms don’t appear to be replacing workers with AI on a significant scale, and we doubt that unemployment rates will be pushed up heavily by AI over the next few years.’ Also, feedback from our SMB clients indicates that potential future labor savings from AI are not a material factor in current headcount decisions.” — CEO Waddell, Q4 2025 call
“The fast-growing use of generative AI by job seekers — particularly to tailor their resumes to client opportunities — has made it more difficult for clients to distinguish among candidates and authenticate their qualifications. This further reinforces the value of our services, including our proprietary data on actual candidate performance.” — CEO Waddell, Q4 2025 call
This is the exact
mirror image of what GLOB’s CFO said on his Q4 call (“The AI Pod model by definition requires less people”). Waddell is citing a third-party economist on a public call as his AI thesis. That is the posture EPAM held going into Q4 2024 before the narrative began breaking.
3. Bill-rate growth decelerating — pricing lever fading while volume tries to turn.
“Contract talent solutions bill rates for the fourth quarter increased 3.2 percent compared to one year ago, adjusted for changes in the mix of revenues by functional specialization, currency and country. This rate for the third quarter was 3.7 percent.” — CFO Buckley, Q4 2025 call
“Contract talent solutions bill rates for the third quarter increased 3.7 percent compared to one year ago… This rate for the second quarter was 3.8 percent.” — CFO Buckley, Q3 2025 call
Mix-adjusted:
3.8% → 3.7% → 3.2% over three consecutive quarters. Same directional deceleration GLOB’s CFO admitted when he said T&M pricing “is not going to be a massive growth this year.” At talent-solutions op margin of 1.1% any further compression flips the segment to operating loss.
4. Protiviti consulting margin broken — same “sales-cycle elongation” vocab as GLOB/EPAM.
“Protiviti’s year-over-year growth rates turned slightly negative during the quarter in part due to tougher prior-year comparables from large project builds, and also due to longer sales cycles and smaller-sized new engagements.” — CEO Waddell, Q3 2025 call
“Protiviti’s year-over-year growth rates showed improvement in the quarter, although it continued to be impacted by tougher prior-year comparables from large project builds, and by longer sales cycles and smaller-sized new engagements.” — CEO Waddell, Q4 2025 call
Adjusted Protiviti GM collapsed from 25.8% (Q3’24) to 23.0% (Q3’25) to 22.8% (Q4’25). The “longer sales cycles and smaller-sized new engagements” language is the
same hedging vocab EPAM introduced in Q4 2025 and GLOB used in both Q3 and Q4 2025. Consulting is breaking across the peer set in unison; RHI is not immune.
5. Quiet workforce reduction already on the tape — 7,400 internal heads, down 3.2% YoY.
“We ended 2025 with 7,400 full-time internal employees in talent solutions, down 3.2 percent from the prior year.” — CFO Buckley, Q4 2025 call
RHI did not brand this as an “optimization plan” the way GLOB did — it’s one sentence in an SG&A footnote. But the cut is already executed. If 2026 revenue prints at the low end of the −3% to −6% guide, a
formal restructuring plan almost certainly follows in H2 2026 — the exact template GLOB ran. That would force a consensus EPS reset not in the current $30 mean PT.
Priced-in check — what the market has already digested
-38.6%from 52w high
($44.68 → $27.44)
-38.3%1-year return
+2.9%YTD return
(already bounced from $21.86 low)
38.74%short % of float
(EXTREME — squeeze setup)
+4.72%MoM Δ shares short
22.0M → 23.0M
6.96days to cover
12.0xFwd P/E
(peer med 9.1x = +32.6%)
19.5xEV/EBITDA
(TTM EBITDA near trough — optical)
$2.8Bmarket cap
EV $2.5B
+9.3%upside to mean target
($27.44 → $30 mean; $27 median; high $50)
9analyst opinions
rec “none” (no buy/sell consensus)
-5.8%rev growth YoY (TTM)
1.7%operating margin
(near breakeven)
8.6%dividend yield
($2.36/yr; not GAAP-covered)
Reading: RHI has been punished — stock −38.6% from high, revenue declining, talent-solutions margin near zero. But the sell-side has only partially capitulated: mean PT $30 = +9% upside, no consensus rating. The residual short edge is (a) Q1 or Q2 2026 guide cut forcing a cluster of analyst downgrades, (b) a recognition that the Fwd P/E premium to peers (+33%) is unwarranted given segment mix is MORE exposed to AI automation than MAN/KFY peers, not less, and (c) an eventual AI narrative break when the Oxford Economics defense no longer holds. But the 8.6% dividend yield and 38.7% short crowding constrain how far and how fast the stock can drop before a squeeze interrupts.
Options chain snapshot (yfinance pull, 2026-04-18)
Spot $27.44. Only 4 expirations; longest = Dec 18, 2026 (243 DTE). OTM10 = $25 strike (~10% OTM). Put-call ATM skew is POSITIVE at 60–243 DTE (puts bid above calls) — the market is already paying up for downside vs GLOB/EPAM where the skew was negative.
| Expiration | DTE | ATM Call IV | ATM Put IV | Put-Call Skew | $25P IV | $25P Bid/Ask | $22.5P Bid/Ask | $25P Vol | $25P OI |
| 2026-05-15 | 26 | 74.9% | 69.7% | −5.2% | 69.7% | $0.90 / $1.15 | $0.40 / $0.70 | 19 | 591 |
| 2026-06-18 | 60 | 58.0% | 68.4% | +10.4% | 68.4% | $1.75 / $2.00 | $0.75 / $1.20 | 15 | 442 |
| 2026-09-18 | 152 | 57.9% | 66.3% | +8.3% | 66.3% | $3.10 / $3.60 | $2.10 / $2.50 | 37 | 178 |
| 2026-12-18 | 243 | 57.5% | 64.8% | +7.3% | 64.8% | $4.00 / $4.70 | $2.80 / $3.50 | 2 | 283 |
Trade structure — defined-risk put spread (NOT long puts) because of 38.7% short crowding:
Primary: Sep 18, 2026 $25/$20 put vertical (152 DTE). Buy the $25P at mid $3.35 (bid $3.10 / ask $3.60, OI 178), sell the $20P at mid $1.45 (bid $1.20 / ask $1.70, OI 263). Net debit ~$1.90, width $5.00, max profit $3.10 (1.63x on risk), breakeven $23.10 (−15.8% from spot $27.44), max loss at/above $25. Thesis: RHI retests the $21.86 52-week low on a Q2 2026 guide cut (announced on the late-July earnings call — inside DTE). Position sizing: OI 178/263 is adequate; expect 8–12% slippage vs mid on exit. Defined risk caps squeeze exposure — even a +50% spike to $41 only costs the debit ($1.90 per spread).
Alternative: Dec 18, 2026 $25/$20 put vertical (243 DTE). Mid debit estimate ~$2.25–$2.40 (OI $25P 283, $20P check ~250+), max profit ~$2.60, 1.15x payoff. Longer runway covers both Q1 (late-April) and Q2 (late-July) 2026 prints. Lower payoff ratio but more catalyst windows captured.
Why not long puts: naked $25P Sep’26 at $3.35 loses $3.35/share if the stock squeezes. With 38.7% of float short and +4.7% MoM short-interest build, a 30–50% squeeze on any modest beat is a real tail. The put spread floors max loss at $1.90 vs $3.35 while preserving most of the upside if the thesis plays out (stock goes to $20).
Why not a front-month (May 15) trade: Front-month ATM call IV (74.9%) is elevated and the first earnings print inside that window (late April 2026, Q1 print) is a binary squeeze trigger if RHI beats the −3 to −6% adj guide. Deep short crowding + “back to sequential growth” narrative = any in-line or better print triggers forced covering. Avoid until post-Q1 earnings.
Kill triggers for the short: (a) Q1 2026 print at or above −3% adj YoY (top of guide) with 2026 guide RAISED or held, (b) permanent-placement rev re-inflecting positive YoY by Q2 2026, (c) any announcement of a share-repurchase acceleration or dividend hike (signals management believes trough is past), (d) Protiviti returning to +YoY growth ahead of the Q3 2026 guided window.
Counter-arguments (the honest bull case)
1. Short crowding at 38.7% of float is a squeeze primed to fire. This is the single biggest reason not to short RHI naked. 23.0M shares short, 6.96 days to cover, only 89.4M float. A mere in-line Q1 2026 print triggers covering cascade. The “return to sequential growth for first time since Q2 2022” narrative gives management a low bar to clear, and weekly revenue trends reported into January were improving off the Q4 exit rate (“Revenues for the first two weeks of January were down 6.6 percent” vs Q4 full of −9.0% for contract). Short interest is +4.72% MoM — still building, not capitulating. Upside squeeze target $35–$40 (+28–46%).
2. AI denial might be correct for THIS business. Barclays’ “low-to-no AI disruption exposure” thesis isn’t stupid. RHI’s placement model has two real AI moats: (a) resume-fraud detection is becoming a real problem for clients as GenAI usage hits 50%+ of job seekers, and RHI has 75 years of proprietary candidate-performance data to authenticate against; (b) SMB accounting is already automated (QuickBooks, Xero) — the incremental GenAI wave mostly hits large-enterprise back-offices where RHI is less exposed. Waddell’s Oxford Economics citation may age fine.
3. 8.6% dividend yield creates a valuation floor. Even if earnings don’t recover in 2026, RHI has $2.5B net cash, a board-approved 5.6M share buyback remaining, and has paid $0.59/q for 4+ years. The dividend is ~2x covered by operating cash flow ($183M Q4 alone), even if not covered by GAAP EPS. Dividend-income holders create a structural $24–$25 floor unless a cut is signaled — RHI has never cut the dividend in its public history.
4. Cyclical recovery is a real live thesis, not a pipedream. NFIB small business hiring plans at highest level since January; rate-cut cycle underway; trade-policy clarity; job openings well above historical averages. 13-quarter-trough staffing cycles historically turn V-shaped when they turn. If the Oct 2025 perm-placement head-fake was just a statistical blip and Q1 2026 actually prints a real inflection, the stock retests $40+ on multiple expansion alone.
RHI vs EPAM — different business, same underlying thesis
Both are shorts on the same knowledge-worker AI-disruption thesis routed through different business models.
| Dimension | EPAM (direct services) | RHI (staffing/placement) |
| Business model | Billable-hour T&M + fixed-fee projects to F500 | Placement fee (perm) + margin on contract billing |
| Customer | Large enterprise tech/financial services | SMB + mid-market, all white-collar functions |
| Job categories disrupted | Contract software engineers / QA / data | Accounting, finance, legal, tech, admin — all |
| Cyclicality | Moderate (project budgets) | High (labor demand turns with macro) |
| Structural AI exposure | Direct: AI writes the code they sell | Indirect: AI reduces the labor they place |
| Revenue trajectory | FY25 +15.4% reported (+4.9% organic); FY26 guide +4.5% | FY25 −5.8%; Q1 2026 guide −3% to −6% adj YoY |
| Management narrative | CFO denial; no AI-reduces-headcount admission | CEO denial + Oxford Economics defense + vetting-moat reframe |
| Short interest / float | 18.1% (+47.6% MoM) | 38.74% (+4.72% MoM) — ~2x EPAM |
| Stock from 52w high | −40.7% | −38.6% |
| Fwd P/E vs peers | 9.4x (below peer median 11.6x) | 12.0x (ABOVE peer median 9.1x by +33%) |
| Upside to analyst mean | Moderate (partially capitulated) | +9.3% — sell-side nearly capitulated |
| Options chain | LEAPS through Jan 2027 available, negative IV skew (puts cheap) | 4 expirations only, longest Dec’26. POSITIVE IV skew (puts expensive) |
| Dividend | None (buybacks only) | 8.6% yield — creates floor |
| Trade structure | Long put viable (cheaper, negative skew) | Put spread mandatory (squeeze + expensive puts) |
Reading: RHI is a worse standalone short than EPAM on three dimensions: (1) squeeze risk is ~2x higher at 38.7% vs 18.1% short interest, (2) puts are already expensive (positive IV skew vs EPAM’s negative skew means RHI put-holders pay a 7–10 vol-point premium over equivalent calls), and (3) the 8.6% dividend creates a structural floor EPAM lacks. RHI is a better short in terms of priced-in edge on one dimension: sell-side has not capitulated — the current +9.3% upside-to-mean is driven by Barclays’ “low-to-no AI disruption” thesis that is demonstrably wrong on segment mix (accounting / legal / tech are precisely where LLM automation lands). Translation: EPAM is the cleaner directional short; RHI is the higher-conviction narrative short but only expressible as a defined-risk spread.
Source documents
Materials saved locally and pulled from SEC EDGAR (Robert Half Inc., CIK 0000315213) + company investor center.
Single-synthesis deep-dive. RHI is the first NEW-CATEGORY short candidate (staffing/placement) in the liquid-put universe after the EPAM/GLOB IT-services cross-read. Full Q3 2025 (Oct 22) and Q4 2025 (Jan 29, 2026) prepared remarks obtained from Robert Half’s investor center and saved to peer_sources/; Seeking Alpha Q&A transcripts returned 403 on WebFetch so supplementary Q&A color is sourced from Investing.com and Insider Monkey summaries. Peer set for priced-in check = ASGN, MAN, KFRC, KFY, HSII (HSII yfinance data unavailable on pull). FMP API returned upgrade/downgrade grade data but returned no mean-recommendation consensus (yfinance shows rec=“none”). Options chain is thin — only 4 expirations through Dec 2026 — but positive IV skew makes put-spread structure the correct expression. Short interest 38.74% of float is the defining risk: trade must be structured as defined-risk spread. Generated 2026-04-18.